(Q35134995)

6 August 2017

1 reference

title

Myelodysplasia--therapeutic response to novel therapy and the need for new diagnostic groups (English)

1 reference

6 August 2017

Schiller GJ

1

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1183-1185

1 reference

Cytogenetic findings in primary and secondary MDS

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

Autoimmune phenomena in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

Thalidomide for the treatment of patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

Morphologic classification of the myelodysplastic syndromes (MDS): Combined utilization of bone marrow aspirates and trephine biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of long-term treatment with recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402939

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2402939

1 reference

Dimensions Publication ID

6 August 2017

1022906450

0 references

1 reference